Nasdaq · CIK 0001526243
PPTA PERPETUA RESOURCES CORP.
Insider trading from SEC Form 4. Last filing 10 d ago. Close $20.64 on Oct 9, 2026, +22% from the 52-week low and -45% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
PPTAOct 9, 2026 · close 20.64
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at PERPETUA RESOURCES CORP., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Robert Alan Dean director sell | $152k 5,708 shares | -20% | +229% from low-9% from high | |
| 39Weak | Robert Alan Dean director sell | $310k 11,490 shares | -38% | +245% from low-5% from high | |
| 40Moderate | Jonathan Cherry (See remarks (3)) sell | $354k 14,911 shares | -29% | +194% from low0% from high | |
| 37Weak | Michael Stephen Wright (See remarks (2)) sell | $183k 10,000 shares | -41% | +133% from low-1% from high | |
| 43Moderate | Paulson & Co. Inc. other buy | $100M 7,575,757 shares | +31% | +62% from low-25% from high | |
| 34Weak | Michael Stephen Wright (See remarks (3)) sell | $90k 6,500 shares | -31% | +78% from low0% from high | |
| 32Weak | Mckinsey Margaret Lyon (See remarks (5)) sell | $220k 20,000 shares | -18% | +36% from low-14% from high | |
| 17Weak | Alan Douglas Haslam (See remarks (6)) sell | $203k 23,008 shares | -16% | - | |
| 45Moderate | Richie Darrin Haddock director buy | $49k 5,780 shares | - | - | |
| 38Weak | Jonathan Cherry (See remarks (1)) buy | $9,976 1,160 shares | - | - | |
| 46Moderate | Andrew Phillip Cole director buy | $76k 9,450 shares | - | - | |
| 46Moderate | Robert Alan Dean director buy | $42k 5,000 shares | +100% | - | |
| 30Weak | Alan Douglas Haslam (See remarks (4)) sell | $96k 10,400 shares | -14% | - | |
| 41Moderate | Alan Douglas Haslam (See remarks (4)) sell | $403k 40,000 shares | -38% | - |
Transactions
The last 92 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Mark E Murchison (See remarks (3)) | MOption exercise Common Shares | +4,000 | - | - | 8,000 | 10 d ago |
| Oct 1, 2026 | Mark E Murchison (See remarks (3)) | MOption exercise Restricted Share Unitsderivative | -4,000 | $0.00 | $0 | 13,836 | 10 d ago |
| Sep 25, 2026 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +747 | $23.42 | $17k | 28,236 | 17 d ago |
| Sep 25, 2026 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +907 | $23.42 | $21k | 69,679 | 17 d ago |
| Sep 25, 2026 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +747 | $23.42 | $17k | 31,913 | 17 d ago |
| Sep 25, 2026 | Jeffrey L Malmen director | AGrant or award Deferred Share Unitsderivative | +747 | $23.42 | $17k | 61,003 | 17 d ago |
| Sep 25, 2026 | Alexander McLeod Sternhell director | AGrant or award Deferred Share Unitsderivative | +747 | $23.42 | $17k | 60,315 | 17 d ago |
| Mar 25, 2026 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +694 | $25.18 | $17k | 26,661 | Mar 27, 2026 |
| Mar 25, 2026 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +843 | $25.18 | $21k | 67,766 | Mar 27, 2026 |
| Mar 25, 2026 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +694 | $25.18 | $17k | 30,338 | Mar 27, 2026 |
| Mar 16, 2026 | Gregory A Fontaine (See remarks (3)) | AGrant or award Restricted Share Unitsderivative | +8,197 | $0.00 | $0 | 8,197 | Mar 18, 2026 |
| Feb 21, 2026 | Jonathan Cherry (See remarks (3)) | MOption exercise Common Shares | +12,725 | $0.00 | $0 | 48,974 | Feb 24, 2026 |
| Feb 21, 2026 | Jonathan Cherry (See remarks (3)) | MOption exercise Restricted Share Unitsderivative | -12,725 | $0.00 | $0 | 47,088 | Feb 24, 2026 |
| Feb 11, 2026 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +2,459 | $30.50 | $75k | 25,967 | Feb 12, 2026 |
| Feb 11, 2026 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +2,459 | $30.50 | $75k | 29,644 | Feb 12, 2026 |
| Feb 11, 2026 | Laura Dove director | AGrant or award Deferred Share Unitsderivative | +2,459 | $30.50 | $75k | 53,119 | Feb 12, 2026 |
| Feb 11, 2026 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +2,459 | $30.50 | $75k | 66,923 | Feb 12, 2026 |
| Feb 11, 2026 | Jonathan Cherry (See remarks (2)) | AGrant or award Restricted Share Unitsderivative | +21,639 | $0.00 | $0 | 59,813 | Feb 12, 2026 |
| Jan 5, 2026 | Robert Alan Dean director | XIn-the-money exercise Common Shares | +9,500 | $8.59 | $82k | 28,010 | Jan 7, 2026 |
| Jan 5, 2026 | Robert Alan Dean director | SOpen-market sale Common Shares | -3,308 | $26.28 | $87k | 24,702 | Jan 7, 2026 |
| Jan 6, 2026 | Robert Alan Dean director | SOpen-market sale Common Shares | -2,400 | $27.14 | $65k | 22,302 | Jan 7, 2026 |
| Jan 5, 2026 | Robert Alan Dean director | XIn-the-money exercise Director and Employee Stock Option (right to buy)derivative | -9,500 | $0.00 | $0 | 0 | Jan 7, 2026 |
| Dec 23, 2025 | Robert Alan Dean director | XIn-the-money exercise Common Shares | +20,000 | $8.56 | $171k | 30,000 | Dec 29, 2025 |
| Dec 23, 2025 | Robert Alan Dean director | SOpen-market sale Common Shares | -6,490 | $27.55 | $179k | 23,510 | Dec 29, 2025 |
| Dec 24, 2025 | Robert Alan Dean director | SOpen-market sale Common Shares | -5,000 | $26.31 | $132k | 18,510 | Dec 29, 2025 |
| Dec 23, 2025 | Robert Alan Dean director | XIn-the-money exercise Director and Employee Stock Option (right to buy)derivative | -20,000 | $0.00 | $0 | 0 | Dec 29, 2025 |
| Dec 23, 2025 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +475 | $27.70 | $13k | 64,464 | Dec 23, 2025 |
| Dec 23, 2025 | Alexander McLeod Sternhell director | AGrant or award Deferred Share Unitsderivative | +378 | $27.70 | $10k | 55,587 | Dec 23, 2025 |
| Dec 23, 2025 | Chris J Robison director | AGrant or award Deferred Share Unitsderivative | +660 | $27.70 | $18k | 69,579 | Dec 23, 2025 |
| Dec 23, 2025 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +378 | $27.70 | $10k | 27,185 | Dec 23, 2025 |
| Dec 23, 2025 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +378 | $27.70 | $10k | 23,508 | Dec 23, 2025 |
| Dec 23, 2025 | Jeffrey L Malmen director | AGrant or award Deferred Share Unitsderivative | +378 | $27.70 | $10k | 56,275 | Dec 23, 2025 |
| Dec 5, 2025 | Timothy Charles Kahl (See remarks (3)) | AGrant or award Restricted Share Unitsderivative | +5,787 | $0.00 | $0 | 5,787 | Dec 9, 2025 |
| Oct 6, 2025 | Jonathan Cherry (See remarks (3)) | AGrant or award Common Shares | +50,000 | $0.00 | $0 | 51,160 | Oct 6, 2025 |
| Oct 6, 2025 | Mark E Murchison (See remarks (3)) | MOption exercise Common Shares | +4,000 | - | - | 4,000 | Oct 6, 2025 |
| Oct 6, 2025 | Jonathan Cherry (See remarks (3)) | SOpen-market sale Common Shares | -14,911 | $23.72 | $354k | 36,249 | Oct 6, 2025 |
| Oct 6, 2025 | Mark E Murchison (See remarks (3)) | AGrant or award Restricted Share Unitsderivative | +12,000 | $0.00 | $0 | 12,000 | Oct 6, 2025 |
| Oct 6, 2025 | Mark E Murchison (See remarks (3)) | MOption exercise Restricted Share Unitsderivative | -4,000 | $0.00 | $0 | 8,000 | Oct 6, 2025 |
| Sep 25, 2025 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +483 | $18.86 | $9,109 | 63,989 | Sep 26, 2025 |
| Sep 25, 2025 | Alexander McLeod Sternhell director | AGrant or award Deferred Share Unitsderivative | +368 | $18.86 | $6,940 | 55,209 | Sep 26, 2025 |
| Sep 25, 2025 | Chris J Robison director | AGrant or award Deferred Share Unitsderivative | +559 | $18.86 | $11k | 68,919 | Sep 26, 2025 |
| Sep 25, 2025 | Jeffrey L Malmen director | AGrant or award Deferred Share Unitsderivative | +368 | $18.86 | $6,940 | 55,897 | Sep 26, 2025 |
| Sep 25, 2025 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +368 | $18.86 | $6,940 | 26,807 | Sep 26, 2025 |
| Sep 25, 2025 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +368 | $18.86 | $6,940 | 23,130 | Sep 26, 2025 |
| Aug 31, 2025 | Michael Stephen Wright (See remarks (2)) | AGrant or award Common Shares | +10,000 | $0.00 | $0 | 24,195 | Sep 3, 2025 |
| Sep 2, 2025 | Michael Stephen Wright (See remarks (2)) | SOpen-market sale Common Shares | -10,000 | $18.31 | $183k | 14,195 | Sep 3, 2025 |
| Jun 25, 2025 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +531 | $13.09 | $6,951 | 22,762 | Jun 26, 2025 |
| Jun 25, 2025 | Chris J Robison director | AGrant or award Deferred Share Unitsderivative | +806 | $13.09 | $11k | 68,360 | Jun 26, 2025 |
| Jun 25, 2025 | Alexander McLeod Sternhell director | AGrant or award Deferred Share Unitsderivative | +531 | $13.09 | $6,951 | 54,841 | Jun 26, 2025 |
| Jun 25, 2025 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +531 | $13.09 | $6,951 | 26,439 | Jun 26, 2025 |
| Jun 25, 2025 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +696 | $13.09 | $9,111 | 63,506 | Jun 26, 2025 |
| Jun 25, 2025 | Jeffrey L Malmen director | AGrant or award Deferred Share Unitsderivative | +531 | $13.09 | $6,951 | 55,529 | Jun 26, 2025 |
| Jun 16, 2025 | Paulson & Co. Inc. other | POpen-market purchase Common Stock, without par valueindirect: By Managed Funds | +7,575,757 | $13.20 | $100M | 32,347,299 | Jun 16, 2025 |
| Apr 24, 2025 | Michael Stephen Wright (See remarks (3)) | SOpen-market sale Common Shares | -6,500 | $13.85 | $90k | 14,195 | Apr 25, 2025 |
| Mar 31, 2025 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +650 | $10.69 | $6,949 | 22,231 | Apr 1, 2025 |
| Mar 31, 2025 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +852 | $10.69 | $9,108 | 62,810 | Apr 1, 2025 |
| Mar 31, 2025 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +650 | $10.69 | $6,949 | 25,908 | Apr 1, 2025 |
| Mar 31, 2025 | Jeffrey L Malmen director | AGrant or award Deferred Share Unitsderivative | +650 | $10.69 | $6,949 | 54,998 | Apr 1, 2025 |
| Mar 31, 2025 | Alexander McLeod Sternhell director | AGrant or award Deferred Share Unitsderivative | +650 | $10.69 | $6,949 | 54,310 | Apr 1, 2025 |
| Mar 31, 2025 | Chris J Robison director | AGrant or award Deferred Share Unitsderivative | +986 | $10.69 | $11k | 67,554 | Apr 1, 2025 |
| Mar 28, 2025 | Mckinsey Margaret Lyon (See remarks (5)) | XIn-the-money exercise Common Shares | +20,000 | $2.45 | $49k | 109,154 | Apr 1, 2025 |
| Mar 28, 2025 | Mckinsey Margaret Lyon (See remarks (5)) | SOpen-market sale Common Shares | -20,000 | $11.00 | $220k | 89,154 | Apr 1, 2025 |
| Mar 28, 2025 | Mckinsey Margaret Lyon (See remarks (5)) | XIn-the-money exercise Director and Employee Stock Option (right to buy)derivative | -20,000 | $0.00 | $0 | 0 | Apr 1, 2025 |
| Mar 5, 2025 | Alan Douglas Haslam (See remarks (6)) | MOption exercise Common Shares | +10,752 | - | - | 76,515 | Mar 7, 2025 |
| Mar 5, 2025 | Alan Douglas Haslam (See remarks (6)) | AGrant or award Common Shares | +64,510 | $0.00 | $0 | 141,025 | Mar 7, 2025 |
| Mar 5, 2025 | Alan Douglas Haslam (See remarks (6)) | SOpen-market sale Common Shares | -3,287 | $8.82 | $29k | 137,738 | Mar 7, 2025 |
| Mar 5, 2025 | Alan Douglas Haslam (See remarks (6)) | SOpen-market sale Common Shares | -19,721 | $8.82 | $174k | 118,017 | Mar 7, 2025 |
| Mar 5, 2025 | Alan Douglas Haslam (See remarks (6)) | MOption exercise Restricted Share Unitsderivative | -10,752 | $0.00 | $0 | 56,500 | Mar 7, 2025 |
| Feb 26, 2025 | Richie Darrin Haddock director | POpen-market purchase Common Shares | +5,780 | $8.56 | $49k | 5,780 | Feb 27, 2025 |
| Feb 24, 2025 | Andrew Phillip Cole director | POpen-market purchase Common Shares | +9,450 | $7.99 | $76k | 9,450 | Feb 24, 2025 |
| Feb 21, 2025 | Jonathan Cherry (See remarks (1)) | POpen-market purchase Common Shares | +1,160 | $8.60 | $9,976 | 1,160 | Feb 24, 2025 |
| Feb 21, 2025 | Robert Alan Dean director | POpen-market purchase Common Shares | +5,000 | $8.32 | $42k | 10,000 | Feb 24, 2025 |
| Feb 21, 2025 | Jonathan Cherry (See remarks (2)) | AGrant or award Restricted Share Unitsderivative | +38,174 | $0.00 | $0 | 38,174 | Feb 21, 2025 |
| Feb 20, 2025 | Alan Douglas Haslam (See remarks (4)) | SOpen-market sale Common Shares | -10,400 | $9.24 | $96k | 65,763 | Feb 21, 2025 |
| Feb 21, 2025 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +3,305 | - | - | 25,258 | Feb 21, 2025 |
| Feb 21, 2025 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +3,305 | - | - | 61,958 | Feb 21, 2025 |
| Feb 21, 2025 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +3,305 | - | - | 21,581 | Feb 21, 2025 |
| Feb 21, 2025 | Laura Dove director | AGrant or award Deferred Share Unitsderivative | +3,305 | - | - | 50,660 | Feb 21, 2025 |
| Feb 21, 2025 | Alan Douglas Haslam (See remarks (4)) | AGrant or award Restricted Share Unitsderivative | +15,886 | $0.00 | $0 | 67,252 | Feb 21, 2025 |
| Feb 16, 2025 | Alan Douglas Haslam (See remarks (3)) | MOption exercise Common Shares | +14,354 | - | - | 76,163 | Feb 19, 2025 |
| Feb 16, 2025 | Alan Douglas Haslam (See remarks (3)) | MOption exercise Restricted Share Unitsderivative | -14,354 | $0.00 | $0 | 51,366 | Feb 19, 2025 |
| Feb 10, 2025 | Alan Douglas Haslam (See remarks (4)) | MOption exercise Common Shares | +11,904 | - | - | 61,809 | Feb 12, 2025 |
| Feb 10, 2025 | Alan Douglas Haslam (See remarks (4)) | MOption exercise Restricted Share Unitsderivative | -11,904 | $0.00 | $0 | 65,720 | Feb 12, 2025 |
| Dec 31, 2024 | Andrew Phillip Cole director | AGrant or award Deferred Share Unitsderivative | +652 | $10.67 | $6,957 | 18,276 | Jan 3, 2025 |
| Dec 31, 2024 | Richie Darrin Haddock director | AGrant or award Deferred Share Unitsderivative | +652 | $10.67 | $6,957 | 21,953 | Jan 3, 2025 |
| Dec 31, 2024 | Laura Dove director | AGrant or award Deferred Share Unitsderivative | +652 | $10.67 | $6,957 | 47,355 | Jan 3, 2025 |
| Dec 31, 2024 | Robert Alan Dean director | AGrant or award Deferred Share Unitsderivative | +854 | $10.67 | $9,112 | 58,653 | Jan 3, 2025 |
| Dec 12, 2024 | Jessica Marie Largent (See remarks (3)) | MOption exercise Common Shares | +5,000 | - | - | 101,892 | Dec 13, 2024 |
| Dec 12, 2024 | Jessica Marie Largent (See remarks (3)) | MOption exercise Restricted Share Unitsderivative | -5,000 | $0.00 | $0 | 97,601 | Dec 13, 2024 |
| Oct 18, 2024 | Alan Douglas Haslam (See remarks (4)) | XIn-the-money exercise Common Shares | +40,000 | $8.55 | $342k | 105,571 | Oct 22, 2024 |
| Oct 18, 2024 | Alan Douglas Haslam (See remarks (4)) | SOpen-market sale Common Shares | -40,000 | $10.07 | $403k | 65,571 | Oct 22, 2024 |
| Oct 18, 2024 | Alan Douglas Haslam (See remarks (4)) | XIn-the-money exercise Director and Employee Stock Option (right to buy)derivative | -40,000 | $0.00 | $0 | 0 | Oct 22, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Jonathan Cherry(See remarks (3))
- Andrew Phillip Coledirector
- Robert Alan Deandirector
- Laura Dovedirector
- Gregory A Fontaine(See remarks (3))
- Richie Darrin Haddockdirector
- Alan Douglas Haslam(See remarks (6))
- Timothy Charles Kahl(See remarks (3))
- Jessica Marie Largent(See remarks (3))
- Mckinsey Margaret Lyon(See remarks (5))
- Jeffrey L Malmenofficer, director
- Mark E Murchison(See remarks (3))
- Paulson & Co. Inc.owner, other
- Chris J Robisondirector
- Alexander McLeod Sternhelldirector
- Michael Stephen Wright(See remarks (2))
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.